The expression level of SOX2 antibody and MAGE antibody in squamous cell carcinoma was significantly higher than that in adenocarcinoma, and the expression level of SOX2 antibody in stage III lung cancer was significantly higher than that in stage I lung cancer. Here, SOX2 is linked to lung carcinoma.